Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Dialysis-Related Amyloidosis Using Lixelle® β2-microglobulin Apheresis Column

NCT02952144 is registered in ClinicalTrials.gov with Kaneka Medical America LLC as lead sponsor.

NCT NCT02952144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02952144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Dialysis-Related Amyloidosis Using Lixelle® β2-microglobulin Apheresis Column
Lead sponsor
Kaneka Medical America LLC
Phase
Not applicable
Overall status
Suspended
Start date
October 1, 2015
Completion date
October 31, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dialysis amyloidosis